TKTL1 and neoplasm: In this perspective, we might speculate that the selective block of TKTL1 through the targeting of PPP metabolic pathway could limit neoplastic development in its early stages represented by hyperplastic and benign tumors, arresting tumor progression in its “primum movens”.